Literature DB >> 28797502

Giant Cell-Containing Tumors of Bone.

Zsolt Orosz1, Nicholas A Athanasou2.   

Abstract

Giant cell-containing tumors of bone are characterized morphologically by the presence of numerous osteoclastic giant cells. Correlation of clinical, radiologic, and laboratory findings is required for accurate histopathologic diagnosis and treatment of a giant cell-containing tumor of bone. In differential diagnosis, it is particularly important to note the age of the patient and the skeletal location of the lesion. This article considers the range of neoplastic and nonneoplastic lesions, which histologically contain numerous osteoclastic giant cells, and focuses on several lesions that frequently enter into the differential diagnosis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone; Giant cell tumors; Osteoclast

Mesh:

Year:  2017        PMID: 28797502     DOI: 10.1016/j.path.2017.04.004

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN: 1875-9157


  3 in total

1.  Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.

Authors:  Inga-Marie Schaefer; Jonathan A Fletcher; G Petur Nielsen; Angela R Shih; Marco L Ferrone; Jason L Hornick; Xiaohua Qian
Journal:  Cancer Cytopathol       Date:  2018-05-14       Impact factor: 5.284

2.  Expression profiles of miRNAs in giant cell tumor of bone showed miR-187-5p and miR-1323 can regulate biological functions through inhibiting FRS2.

Authors:  Yuanhan Jin; Jing Zhang; Hao Zhu; Gentao Fan; Guangxin Zhou
Journal:  Cancer Med       Date:  2020-03-10       Impact factor: 4.452

Review 3.  Role of cancer stem cells in the development of giant cell tumor of bone.

Authors:  Abdul Rouf War; Kai Dang; Shanfen Jiang; Zhongwei Xiao; Zhiping Miao; Tuanmin Yang; Yu Li; Airong Qian
Journal:  Cancer Cell Int       Date:  2020-04-25       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.